Matrix Metalloproteinases Gordon Conference
Matrix Metalloproteinases Gordon Conference
批准号:
7425012
负责人:
Carl Peter Blobel
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-01 至 2010-05-31
关键词:
ADAMTSAgeAmerican Association of Cancer ResearchAneurysmAreaArthritisAtherosclerosisAttentionBiochemistryBone ResorptionCardiovascular systemCellsCellular biologyChemicalsCollaborationsComplementary DNACorneal UlcerDataDevelopmentDisciplineDiseaseEncephalomyelitisEnzymesExtracellular MatrixExtracellular Matrix DegradationEye diseasesFamilyFeesFibrosisFosteringFundingGelatinase AGene Expression RegulationGene FamilyGenesGeneticGlomerulonephritisGoalsHomologous GeneHumanInfectionInflammationInfluentialsInfusion proceduresInternationalLengthLiteratureLungMalignant NeoplasmsMatrix MetalloproteinasesMemoryMetalloproteasesMetalloproteinase GeneMolecularMontanaMorphogenesisNervous system structureNeurodegenerative DisordersOvulationParticipantPathologyPeptide HydrolasesPeriodontitisPhysiciansPhysiologicalPhysiologyPlantsPlayPositioning AttributePostdoctoral FellowProteinsProteomicsReagentReceptor ActivationRelative (related person)ResearchResearch PersonnelResortRoleScientistSkiingStem Cell DevelopmentStromelysin 1StructureStudentsSystemTadpolesTechnologyTissuesTravelUlcerWorkWound Healingabstractingcareercollagenaseenzyme activityenzyme substrateflyinhibitor/antagonistinterestmeetingsmembermicroorganismnatural Blastocyst Implantationnext generationplanetary Atmospherepostersprogramsstructural biologysymposiumtherapeutic target
中文摘要
描述(由申请人提供):戈登研究会议将选定科学领域的活跃研究人员聚集在一起,目的是通过正式的演讲和广泛的讨论来定义和分析重要问题、最新进展和研究机会。本提案的具体目的是为2005年戈登基质金属蛋白酶(MMPs)研究会议以及2007年和2009年的会议获得部分资金。2005年会议代表了MMP戈登研究会议的第七届两年一次的会议,并将在大天空度假村,大天空,蒙大拿举行。MMPs及其亲属在正常发育和生理以及与组织破坏相关的许多病理条件中发挥核心作用,包括癌症、关节炎、牙周炎、溃疡、动脉粥样硬化、肺纤维化、退行性眼病、感染和炎症。会议将继续提供一个论坛,讨论结构、功能、靶点、抑制剂和分子机制方面的最新进展。我们的目标是创造一种氛围,让有共同兴趣的研究人员相互联系,并让那些拥有更多样化方法的研究人员相互促进。这个。2005年会议将包括八个科学会议:1。金属蛋白酶工具箱:酶和底物的结构生物学降解,可视化MMPs;2. 金属蛋白酶在干细胞发育和衰老中的作用3. 炎症中的金属蛋白酶;4. 金属蛋白酶在神经系统退行性疾病、记忆和衰老中的作用5. 亚当和亚当家族在发育和疾病中的作用6. 金属蛋白酶在癌症中的作用;6. 金属蛋白酶抑制剂tevips等的研究8、金属蛋白酶基因调控、细胞生物学、活化与受体;9. mmp——下一代。会议计划举办两场海报会议,鼓励学生、博士后和青年研究人员与资深研究人员一起介绍他们的工作。我们鼓励所有与会者为海报环节提交摘要,让所有与会者都有机会展示数据并充分参与讨论。传统上,本次会议汇集了不同的国际学术和工业科学家,他们的兴趣范围从基本的分子、细胞和生理机制,到对MMPs作为治疗靶点感兴趣的医生科学家。有限的出席人数,集中的科学会议,以及非常成功的海报会议相结合,为思想交流提供了一个令人兴奋的论坛,并为对MMPs,相关酶及其抑制剂感兴趣的不同群体的科学家提供了广泛的参与机会。因此,我们请求提供资金,部分支持MMPs问题全球协调委员会,以确保在这一关键和极具影响力的会议上提供最相关和最新的信息。
英文摘要
DESCRIPTION (provided by applicant): Gordon Research Conferences bring together active researchers in a selected scientific field with the purpose of defining and analyzing important problems, recent advances and opportunities for research through both formal presentations and extensive discussion. The specific aim of this proposal is to obtain partial funding for the 2005 Gordon Research Conference on Matrix Metalloproteinases (MMPs) and for the conferences in 2007 and 2009. The 2005 Conference represents the 7th biennial meeting of the MMP Gordon Research Conference, and will be held at Big Sky Resort, Big Sky, Montana. MMPs and their relatives play a central role in normal development and physiology and in many pathological conditions associated with tissue destruction, including cancer, arthritis, periodontitis, ulcerations, atherosclerosis, lung fibrosis, degenerative eye diseases, infection and inflammation. The conference will continue to provide a forum for discussion of the latest advances in structure, function, targets, inhibitors and molecular mechanisms. The goal is to create an atmosphere that will weave threads among investigators with common interests, and cross-fertilize those with more diverse approaches. The .2005 conference will consist of eight Scientific Sessions: 1. The Metalloproteinase Toolbox: Structural Biology of Enzymes and Substrates; The Degradome, Visualizing MMPs; 2. Metalloproteinases in Stem Cells, Development and Ageing; 3. Metalloproteinases In Inflammation; 4. Metalloproteinases in The Nervous System-Neurodegenerative Diseases, Memory and Aging; 5. ADAM and ADAMTS Families In Development And Disease; 6. Metalloproteinases in Cancer; 6. Inhibitors Of Metalloproteinases-TEVIPs And Others; 8, Metalloproteinase Gene Regulation, Cell Biology, Activation And Receptors; 9. MMPs-The Next Generation. Two Poster Sessions are planned for the conference to encourage students, postdoctoral fellows and young investigators to join senior investigators in presenting their work. All meeting participants will be encouraged to submit an abstract for the Poster Sessions, allowing all attendees the opportunity to present data and fully participate in discussions. Traditionally, this conference brings together a diverse international group of academic and industrial scientists with interests ranging from basic molecular, cellular and physiological mechanisms MMP action, to physician-scientists interested in MMPs as therapeutic targets. The limited attendance, focused Scientific Sessions, and highly successful Poster Sessions combine to provide an exciting forum for the exchange of ideas and to provide extensive opportunities for participation by a diverse group of scientists interested in MMPs, related enzymes and their inhibitors. Therefore, we are requesting funds to partially support the GRC on MMPs to assure that the most relevant and up-to-date information is featured at this pivotal and highly influential meeting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of iRhoms and ADAM17 in EGFR and TNFalpha signaling
-
批准号:10544994
-
项目类别:
-
资助金额:$41.14万
-
财政年份:2020
-
负责人:Carl Peter Blobel
-
依托单位:
Role of iRhoms and ADAM17 in EGFR and TNFalpha signaling
-
批准号:10316173
-
项目类别:
-
资助金额:$41.14万
-
财政年份:2020
-
负责人:Carl Peter Blobel
-
依托单位:
ADAMs: Key regulators of EGFR signaling
-
批准号:7922909
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2009
-
负责人:Carl Peter Blobel
-
依托单位:
Matrix Metalloproteinases Gordon Conference
-
批准号:7029006
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2005
-
负责人:Carl Peter Blobel
-
依托单位:
Role of ADAMs 9 and 15 in Proliferative Retinopathy
-
批准号:7768200
-
项目类别:
-
资助金额:$6.94万
-
财政年份:2004
-
负责人:Carl Peter Blobel
-
依托单位:
Role of ADAMs 9 and 15 in Proliferative Retinopathy
-
批准号:6807074
-
项目类别:
-
资助金额:$5.14万
-
财政年份:2004
-
负责人:Carl Peter Blobel
-
依托单位:
Role of ADAMs 9 and 15 in Proliferative Retinopathy
-
批准号:7123818
-
项目类别:
-
资助金额:$51.37万
-
财政年份:2004
-
负责人:Carl Peter Blobel
-
依托单位:
Role of ADAMs 9 and 15 in Proliferative Retinopathy
-
批准号:7483010
-
项目类别:
-
资助金额:$40.44万
-
财政年份:2004
-
负责人:Carl Peter Blobel
-
依托单位:
Role of ADAMs 9 and 15 in Proliferative Retinopathy
-
批准号:6946780
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2004
-
负责人:Carl Peter Blobel
-
依托单位:
Role of ADAMs 9 and 15 in Proliferative Retinopathy
-
批准号:7280325
-
项目类别:
-
资助金额:$51.38万
-
财政年份:2004
-
负责人:Carl Peter Blobel
-
依托单位:
Role of ADAMs 9 and 15 in Proliferative Retinopathy
-
批准号:7081893
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2004
-
负责人:Carl Peter Blobel
-
依托单位:
Role of ADAMs 9 and 15 in Proliferative Retinopathy
-
批准号:7080295
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2004
-
负责人:Carl Peter Blobel
-
依托单位:
Functional and biochemical studies of ADAM19
-
批准号:6700807
-
项目类别:
-
资助金额:$25.57万
-
财政年份:2002
-
负责人:Carl Peter Blobel
-
依托单位:
ADAMs: Key Regulators of EGFR Signaling
-
批准号:8134725
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2002
-
负责人:Carl Peter Blobel
-
依托单位:
ADAMs: Key regulators of EGFR signaling
-
批准号:7348434
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2002
-
负责人:Carl Peter Blobel
-
依托单位:
ADAMs: Key regulators of EGFR signaling
-
批准号:7174765
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2002
-
负责人:Carl Peter Blobel
-
依托单位:
Functional and biochemical studies of ADAM19
-
批准号:6994066
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2002
-
负责人:Carl Peter Blobel
-
依托单位:
ADAMs: Key Regulators of EGFR Signaling
-
批准号:9129170
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2002
-
负责人:Carl Peter Blobel
-
依托单位:
ADAMs: Key Regulators of EGFR Signaling
-
批准号:8321956
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2002
-
负责人:Carl Peter Blobel
-
依托单位:
ADAMs: Key regulators of EGFR signaling
-
批准号:7578889
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2002
-
负责人:Carl Peter Blobel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: